{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:11:48Z","timestamp":1773385908751,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL127522"],"award-info":[{"award-number":["U01HL127522"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL127522"],"award-info":[{"award-number":["U01HL127522"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R41AI136071"],"award-info":[{"award-number":["R41AI136071"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R41AI136071"],"award-info":[{"award-number":["R41AI136071"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002386"],"award-info":[{"award-number":["TL1TR002386"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current TB diagnostic methods available have been developed for adults and development efforts have neglected the differences in disease and sampling that occur between adults and children. Diagnostic challenges are even greater in HIV co-infected children and infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      We established a sandwich ELISA assay to detect\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      modified lipoprotein (TLP) ex vivo in plasma. The study population contains plasma samples from 21 patients with active TB and 24 control samples with no TB, collected in the International Maternal Pediatric Adolescent AIDS Clinical Trails (IMPAACT) P1041 study. Retrospective analysis was performed and the results demonstrate that the median plasma levels of TLP in control subjects are 2.7 fold higher than the median plasma values in active TB subjects (p\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma levels of TLP are elevated with active TB disease in HIV positive subjects and deserves further exploration as an indicator for TB detection in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07140-9","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T06:03:19Z","timestamp":1645077799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5162-5030","authenticated-orcid":false,"given":"Xinxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1436-3366","authenticated-orcid":false,"given":"Matthew F.","family":"Wipperman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-7253","authenticated-orcid":false,"given":"Sharon","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-7760","authenticated-orcid":false,"given":"Nicole S.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"7140_CR1","unstructured":"Global tuberculosis report. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336069\/9789240013131-eng.pdf."},{"issue":"5","key":"7140_CR2","first-page":"675","volume":"8","author":"MF Cotton","year":"2004","unstructured":"Cotton MF, Schaaf HS, Hesseling AC, Madhi SA. HIV and childhood tuberculosis: the way forward. Int J Tuberculosis Lung Dis. 2004;8(5):675\u201382.","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"11","key":"7140_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/adc.2004.070797","volume":"90","author":"BJ Marais","year":"2005","unstructured":"Marais BJ, Gie RP, Obihara CC, Hesseling AC, Schaaf HS, Beyers N. Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child. 2005;90(11):1162\u20135.","journal-title":"Arch Dis Child"},{"issue":"12","key":"7140_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/INF.0b013e3181eaefff","volume":"29","author":"DP Moore","year":"2010","unstructured":"Moore DP, Klugman KP, Madhi SA. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J. 2010;29(12):1099\u20131004.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"7140_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/adc.82.4.305","volume":"82","author":"HJ Zar","year":"2000","unstructured":"Zar HJ, Tannenbaum E, Apolles P, Roux P, Hanslo D, Hussey G. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child. 2000;82(4):305\u20138.","journal-title":"Arch Dis Child"},{"key":"7140_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-8-1","volume":"8","author":"E Walters","year":"2008","unstructured":"Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr. 2008;8:1.","journal-title":"BMC Pediatr"},{"issue":"5","key":"7140_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0962-8479(96)90117-3","volume":"77","author":"PM Jeena","year":"1996","unstructured":"Jeena PM, Mitha T, Bamber S, Wesley A, Coutsoudis A, Coovadia HM. Effects of the human immunodeficiency virus on tuberculosis in children. Tubercle Lung Dis. 1996;77(5):437\u201343.","journal-title":"Tubercle Lung Dis"},{"issue":"3","key":"7140_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/adc.69.3.371","volume":"69","author":"HS Schaaf","year":"1993","unstructured":"Schaaf HS, Gie RP, Beyers N, Smuts N, Donald PR. Tuberculosis in infants less than 3 months of age. Arch Dis Child. 1993;69(3):371\u20134.","journal-title":"Arch Dis Child"},{"issue":"8","key":"7140_CR9","first-page":"672","volume":"6","author":"PM Jeena","year":"2002","unstructured":"Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tubercul Lung Dis. 2002;6(8):672\u20138.","journal-title":"Int J Tubercul Lung Dis"},{"issue":"5","key":"7140_CR10","first-page":"448","volume":"4","author":"SA Madhi","year":"2000","unstructured":"Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper PA. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int J Tubercul Lung Dis. 2000;4(5):448\u201354.","journal-title":"Int J Tubercul Lung Dis"},{"issue":"4","key":"7140_CR11","first-page":"392","volume":"8","author":"BJ Marais","year":"2004","unstructured":"Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tubercul Lung Dis. 2004;8(4):392\u2013402.","journal-title":"Int J Tubercul Lung Dis"},{"issue":"Suppl 2","key":"7140_CR12","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiu821","volume":"211","author":"CM Denkinger","year":"2015","unstructured":"Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, et al. Defining the needs for next generation assays for tuberculosis. J Infect Dis. 2015;211(Suppl 2):S29-38.","journal-title":"J Infect Dis"},{"issue":"3","key":"7140_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/pathogens9030218","volume":"9","author":"AE Abdalla","year":"2020","unstructured":"Abdalla AE, Ejaz H, Mahjoob MO, Alameen AAM, Abosalif KOA, Elamir MYM, Mousa MA. Intelligent mechanisms of macrophage apoptosis subversion by Mycobacterium. Pathogens. 2020;9(3):218.","journal-title":"Pathogens"},{"key":"7140_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fimmu.2018.00459","volume":"9","author":"M Genoula","year":"2018","unstructured":"Genoula M, Marin Franco JL, Dupont M, Kviatcovsky D, Milillo A, Schierloh P, Morana EJ, Poggi S, Palmero D, Mata-Espinosa D, et al. Formation of foamy macrophages by tuberculous pleural effusions is triggered by the interleukin-10\/signal transducer and activator of transcription 3 axis through ACAT upregulation. Front Immunol. 2018;9:459.","journal-title":"Front Immunol"},{"issue":"9","key":"7140_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni.1781","volume":"10","author":"DG Russell","year":"2009","unstructured":"Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 2009;10(9):943\u20138.","journal-title":"Nat Immunol"},{"issue":"4","key":"7140_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/mmi.13482","volume":"102","author":"A Viljoen","year":"2016","unstructured":"Viljoen A, Blaise M, de Chastellier C, Kremer L. MAB_3551c encodes the primary triacylglycerol synthase involved in lipid accumulation in Mycobacterium abscessus. Mol Microbiol. 2016;102(4):611\u201327.","journal-title":"Mol Microbiol"},{"issue":"2","key":"7140_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/IAI.01196-13","volume":"82","author":"I Caire-Brandli","year":"2014","unstructured":"Caire-Brandli I, Papadopoulos A, Malaga W, Marais D, Canaan S, Thilo L, de Chastellier C. Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis. Infect Immun. 2014;82(2):476\u201390.","journal-title":"Infect Immun"},{"issue":"12","key":"7140_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.it.2019.10.002","volume":"40","author":"V Guerrini","year":"2019","unstructured":"Guerrini V, Gennaro ML. Foam cells: one size doesn\u2019t fit all. Trends Immunol. 2019;40(12):1163\u201379.","journal-title":"Trends Immunol"},{"key":"7140_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fmicb.2020.01394","volume":"11","author":"P Agarwal","year":"2020","unstructured":"Agarwal P, Combes TW, Shojaee-Moradie F, Fielding B, Gordon S, Mizrahi V, Martinez FO. Foam cells control Mycobacterium tuberculosis Infection. Front Microbiol. 2020;11:1394.","journal-title":"Front Microbiol"},{"issue":"1","key":"7140_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2012.12.020","volume":"227","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Nakazato Y, Saiki R, Igarashi K, Kitada M, Ishii I. Acrolein-conjugated low-density lipoprotein induces macrophage foam cell formation. Atherosclerosis. 2013;227(1):51\u20137.","journal-title":"Atherosclerosis"},{"issue":"15","key":"7140_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","volume":"98","author":"P Holvoet","year":"1998","unstructured":"Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98(15):1487\u201394.","journal-title":"Circulation"},{"issue":"8","key":"7140_CR22","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.4049\/jimmunol.174.8.5007","volume":"174","author":"RE Geisel","year":"2005","unstructured":"Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol. 2005;174(8):5007\u201315.","journal-title":"J Immunol"},{"issue":"1","key":"7140_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","volume":"296","author":"A Knappik","year":"2000","unstructured":"Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, Hoess A, Wolle J, Pluckthun A, Virnekas B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol. 2000;296(1):57\u201386.","journal-title":"J Mol Biol"},{"issue":"1","key":"7140_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jmb.2011.08.012","volume":"413","author":"J Prassler","year":"2011","unstructured":"Prassler J, Thiel S, Pracht C, Polzer A, Peters S, Bauer M, Norenberg S, Stark Y, Kolln J, Popp A, et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol. 2011;413(1):261\u201378.","journal-title":"J Mol Biol"},{"issue":"1","key":"7140_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1011214","volume":"365","author":"SA Madhi","year":"2011","unstructured":"Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, Jean-Philippe P, McSherry G, Mitchell C, Team PS. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011;365(1):21\u201331.","journal-title":"N Engl J Med"},{"key":"7140_CR26","unstructured":"A randomized, double blind, placebo controlled trial to determine the efficacy of isoniazid (INH) in preventing tuberculosis disease and latent tuberculosis infection among infants with perinatal exposure to HIV. https:\/\/impaactnetwork.org\/DocFiles\/P1041\/P1041V2_11Jul07.pdf."},{"issue":"2","key":"7140_CR27","doi-asserted-by":"publisher","first-page":"e0148649","DOI":"10.1371\/journal.pone.0148649","volume":"11","author":"A Gupta","year":"2016","unstructured":"Gupta A, Montepiedra G, Gupte A, Zeldow B, Jubulis J, Detrick B, Violari A, Madhi S, Bobat R, Cotton M, et al. Low vitamin-D levels combined with PKP3-SIGIRR-TMEM16J host variants is associated with tuberculosis and death in HIV-infected and -exposed infants. PloS One. 2016;11(2):e0148649.","journal-title":"PloS One"},{"issue":"2","key":"7140_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2010.03.031","volume":"211","author":"M Yoshida","year":"2010","unstructured":"Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, Takizawa H, Kashiwado K, Suzuki N, Fukuda K, et al. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis. 2010;211(2):475\u20139.","journal-title":"Atherosclerosis"},{"issue":"5","key":"7140_CR29","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4049\/jimmunol.178.5.3161","volume":"178","author":"MP Puissegur","year":"2007","unstructured":"Puissegur MP, Lay G, Gilleron M, Botella L, Nigou J, Marrakchi H, Mari B, Duteyrat JL, Guerardel Y, Kremer L, et al. Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and beta1 integrin-mediated pathway. J Immunol. 2007;178(5):3161\u20139.","journal-title":"J Immunol"},{"key":"7140_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fphar.2018.00071","volume":"9","author":"S Tedesco","year":"2018","unstructured":"Tedesco S, De Majo F, Kim J, Trenti A, Trevisi L, Fadini GP, Bolego C, Zandstra PW, Cignarella A, Vitiello L. Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization? Front Pharmacol. 2018;9:71.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7140_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2011.03.025","volume":"217","author":"N Nezami","year":"2011","unstructured":"Nezami N, Ghorbanihaghjo A, Rashtchizadeh N, Argani H, Tafrishinejad A, Ghorashi S, Hajhosseini B. Atherogenic changes of low-density lipoprotein susceptibility to oxidation, and antioxidant enzymes in pulmonary tuberculosis. Atherosclerosis. 2011;217(1):268\u201373.","journal-title":"Atherosclerosis"},{"issue":"15","key":"7140_CR32","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","volume":"97","author":"FM Sacks","year":"1998","unstructured":"Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial. Circulation. 1998;97(15):1446\u201352.","journal-title":"Circulation"},{"key":"7140_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/joim.12212","volume":"275","author":"J Weiner","year":"2014","unstructured":"Weiner J, Kaufmann SH. Recent advances towards tuberculosis control: vaccines and biomarkers. J Intern Med. 2014;275:467.","journal-title":"J Intern Med"},{"issue":"5","key":"7140_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri2960","volume":"11","author":"G Walzl","year":"2011","unstructured":"Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol. 2011;11(5):343\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"7140_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/resp.13272","volume":"23","author":"D Goletti","year":"2018","unstructured":"Goletti D, Lee MR, Wang JY, Walter N, Ottenhoff THM. Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease. Respirology. 2018;23(5):455\u201366.","journal-title":"Respirology"},{"issue":"3","key":"7140_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4049\/jimmunol.1402894","volume":"195","author":"JJ Athman","year":"2015","unstructured":"Athman JJ, Wang Y, McDonald DJ, Boom WH, Harding CV, Wearsch PA. Bacterial membrane vesicles mediate the release of Mycobacterium tuberculosis lipoglycans and lipoproteins from infected macrophages. J Immunol. 2015;195(3):1044\u201353.","journal-title":"J Immunol"},{"issue":"3","key":"7140_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1128\/AAC.47.3.833-836.2003","volume":"47","author":"J Grosset","year":"2003","unstructured":"Grosset J. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother. 2003;47(3):833\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"7140_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MOL.0000000000000525","volume":"29","author":"AN Orekhov","year":"2018","unstructured":"Orekhov AN. LDL and foam cell formation as the basis of atherogenesis. Curr Opin Lipidol. 2018;29(4):279\u201384.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"7140_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/COH.0000000000000345","volume":"12","author":"L Scott","year":"2017","unstructured":"Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM. Diagnosis of opportunistic infections: HIV co-infections\u2014tuberculosis. Curr Opin HIV AIDS. 2017;12(2):129\u201338.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07140-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T06:03:42Z","timestamp":1645077822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7140"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07140-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.26.21254411","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The NIH-IMPAACT Scientific Leadership Group (SLG) reviewed and approved the use of P1041 trial samples under NWCS127. The Wits Health Consortium, University of Witwatersrand, South Africa provided deidentified samples to Stony Brook University for which informed consent had been obtained from a parent and\/or legal guardian of all participants. The Stony Brook University CORIHS determined the experiments (IRB# 687246-1) in this manuscript were not human subjects research (exemption 4) under either United States Department of Health and Human Services 45 CFR part 46, subpart A, \u201cthe Common Rule\u201d or United States Food and Drug Administration (FDA) Regulations 21 CFR parts 50, 56, 312 and 812.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NSS is President and co-owner of Chronus Pharmaceuticals, Inc. XY was an employee of both Chronus Pharmaceuticals, Inc and Stony Brook University. All intellectual property is currently owned by Stony Brook University. SN and MFW have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}